Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control
Authors
Keywords
-
Journal
BIOMETRICAL JOURNAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2019-07-02
DOI
10.1002/bimj.201800395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bayesian clinical trial design using historical data that inform the treatment effect
- (2018) Matthew A Psioda et al. BIOSTATISTICS
- Practical experiences of adopting assurance as a quantitative framework to support decision making in drug development
- (2018) Adam Crisp et al. PHARMACEUTICAL STATISTICS
- Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approach
- (2018) Annette Kopp-Schneider et al. BIOMETRICAL JOURNAL
- Power priors based on multiple historical studies for binary outcomes
- (2018) Isaac Gravestock et al. BIOMETRICAL JOURNAL
- Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects
- (2017) David Dejardin et al. PHARMACEUTICAL STATISTICS
- Adaptive power priors with empirical Bayes for clinical trials
- (2017) Isaac Gravestock et al. PHARMACEUTICAL STATISTICS
- Statistical modeling for Bayesian extrapolation of adult clinical trial information in pediatric drug evaluation
- (2017) Margaret Gamalo-Siebers et al. PHARMACEUTICAL STATISTICS
- Including historical data in the analysis of clinical trials: Is it worth the effort?
- (2017) Joost van Rosmalen et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Idle thoughts of a ‘well-calibrated’ Bayesian in clinical drug development
- (2016) Andrew P. Grieve PHARMACEUTICAL STATISTICS
- Extrapolation of efficacy and other data to support the development of new medicines for children: A systematic review of methods
- (2016) Ian Wadsworth et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- On the Use of Co-Data in Clinical Trials
- (2016) Beat Neuenschwander et al. Statistics in Biopharmaceutical Research
- How to test hypotheses if you must
- (2015) Andrew P. Grieve PHARMACEUTICAL STATISTICS
- The power prior: theory and applications
- (2015) Joseph G. Ibrahim et al. STATISTICS IN MEDICINE
- Robust meta-analytic-predictive priors in clinical trials with historical control information
- (2014) Heinz Schmidli et al. BIOMETRICS
- Use of historical control data for assessing treatment effects in clinical trials
- (2013) Kert Viele et al. PHARMACEUTICAL STATISTICS
- Similarities and Differences of Bayesian Designs and Adaptive Designs for Medical Devices: A Regulatory View
- (2013) Gregory Campbell Statistics in Biopharmaceutical Research
- The inclusion of historical control data may reduce the power of a confirmatory study
- (2011) Robert L. Cuffe STATISTICS IN MEDICINE
- Summarizing historical information on controls in clinical trials
- (2010) Beat Neuenschwander et al. Clinical Trials
- Historical control monotherapy design in the treatment of epilepsy
- (2010) Jacqueline A. French et al. EPILEPSIA
- A note on the power prior
- (2009) Beat Neuenschwander et al. STATISTICS IN MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More